OncoCyte
OCX
$2.48
Share price
1.64%
Change (1 day)
818.52%
Change (1 year)
Categories
EPS for OncoCyte (OCX)
EPS in 2023 (TTM): -$10.27
According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -$10.27. In 2022 the company made an earnings per share (EPS) of -$13.28 an increase over its 2021 EPS that were of -$14.20.
EPS history for OncoCyte from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$10.27 | -22.67% |
| 2022 | -$13.28 | -6.48% |
| 2021 | -$14.20 | 54.35% |
| 2020 | -$9.20 | 6.98% |
| 2019 | -$8.60 | 2.38% |
| 2018 | -$8.40 | -34.38% |
| 2017 | -$12.80 | 48.84% |
| 2016 | -$8.60 | -35.18% |
| 2015 | -$13.27 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -78.77% | 🇺🇸 USA |